Clinical Research Directory
Browse clinical research sites, groups, and studies.
Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)
Sponsor: Sirtex Medical
Summary
This registry seeks to prospectively gather a large repository of comprehensive observational data reflecting routine use of SIR-Spheres in patients diagnosed with unresectable HCC or unresectable liver metastases from mCRC refractory to or intolerant to chemotherapy, in order to assess clinical response in a real-world setting and further validate the safe and appropriate use of SIR-Spheres
Official title: Observational Study to Assess Real-World Outcomes in Patients With Unresectable Liver Tumors Initiating Treatment With SIR-Spheres (Y-90 Resin Microspheres) (SIRtain Registry)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
845
Start Date
2023-06-19
Completion Date
2029-06
Last Updated
2024-11-27
Healthy Volunteers
No
Interventions
SIRT
Selective internal radiation therapy with SIR-Spheres Y90 resin microspheres.
Locations (9)
Hôpital Beaujon
Clichy, Cedex, France
Hopital Henri Mondor
Créteil, Paris, France
Hospices Civils de Lyon HCL Centre Hospitalier Lyon-Sud
Pierre-Bénite, Rhône, France
Hospital Universitario Puerta de Hierro - Majadahonda
Majadahonda, Madrid, Spain
Hospital General Universitario Gregorio Marañon
Madrid, Spain
Hospital Clinico Universitario de Valencia
Valencia, Spain
The Christie Hospital
Manchester, Lancashire, United Kingdom
Kings College Hospital
London, United Kingdom
Hammersmith Hospital
London, United Kingdom